Table legend |
|
Legend to Inherited mutation Tables |
|
Nomenclature
are according to the standard mutation nomenclature recommendations
(http://www.hgvs.org/mutnomen/). The numbering for the mutations refers to
the position relative to the start codon (ATG) of the full-length SCN |
|
|
|
Phenotype |
|
ADNFLE |
Autosomal
dominant nocturnal frontal lobe epilepsy |
AGTCS |
Afebrile
generalized tonic-clonic seizures |
ASD |
Autism spectrum disorder |
BOE+FHM |
Benign
occipital epilepsy+ familial hemiplegic migraine |
CGE |
Cryptogenic
generalized epilepsy |
EA with FS+ |
Epilepsy-aphasia
with FS+ |
EE |
Epileptic encephalopathy |
EP+FHM |
Epilepsy +
familial hemiplegic migraine |
FE(MCDs) |
Focal
epilepsy(malformations of cortical development) |
FHM |
Familial
hemiplegic migraine |
FHM + ERDB |
Familial
hemiplegic migraine + elicited repetitive daily blindness |
FS |
Febrile
seizures |
FS+ |
Febrile
seizures plus |
GC |
Generalized
convulsions |
GEFS+ |
Generalized
epilepsy with febrile seizures plus |
IE |
Intractable
epilepsy |
IGE |
Idiopathic generalized epilepsy |
IME+ASD |
Intractable
myoclonic epilepsy and ASD |
JME |
Juvenile
myoclonic epilepsy |
MAE |
Myoclonic
astatic epilepsy |
NIE |
Neonatal-infantile
epilepsy |
PEFS+ |
Partial
epilepsy with febrile seizures plus |
PS |
Panayiotopoulos
syndrome |
Rasmussen |
Rasmussen
encephalitis |
SEHT |
Symptomatic epilepsy after head trauma |
SIMFE |
Severe
infantile multifocal epilepsy |
SMEB |
SMEI
borderline |
SMEI |
Severe
myoclonic epilepsy of infancy |
NA |
Not available:
the phenotype of the proband could not be analyzed or specify |
Unclassified |
The epilepsy
was not classified |
|
|
Inheritance |
|
Familial |
A familial
case is defined by the existence of 2 or more family members carrying the
same SCN |
Mosaic(mosaic
level) |
Mosaic
mutation level was quantitively determined, with heterozygous mutation was
set as 50%. |
NA |
Not available:
family members of the proband could not be analyzed or specify |
No symptom |
No symptomatic |
P |
Penetrance:
the number of affected individuals with the mutation/total number of
individuals with the mutation.The mosaic carriers were excluded considering
that individuals with low level of mutation could be asymptomatic. |
Copyright ©2014 Institute of Neuroscience and The Second Affiliated Hospital of Guangzhou Medical University
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China
Collaborative Innovation Center for Neurogenetics and Channelopathies, Guangzhou 510260, China.